{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T16:06:01Z","timestamp":1792944361134,"version":"4.5.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,23]]},"DOI":"10.7759\/cureus.65225","type":"journal-article","created":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T03:51:16Z","timestamp":1721793076000},"source":"Crossref","is-referenced-by-count":2,"title":["Expression of E-cadherin in Hyperplastic Endometrium: A Retrospective Analysis"],"prefix":"10.7759","author":[{"given":"Monisha Rita","family":"Jayaraman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niveditha","family":"EN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volga","family":"Harikrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Endometrial hyperplasia","author":"Singh G","year":"2024","unstructured":"Singh G, Cue L, Puckett Y. Endometrial hyperplasia. StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-021-06380-5","article-title":"Endometrial hyperplasia as a risk factor of endometrial cancer","volume":"306","author":"Nees LK","year":"2022","unstructured":"Nees LK, Heublein S, Steinmacher S, Juhasz-B\u00f6ss I, Brucker S, Tempfer CB, Wallwiener M. Endometrial hyperplasia as a risk factor of endometrial cancer. Arch Gynecol Obstet. 2022, 306:407-21. 10.1007\/s00404-021-06380-5","journal-title":"Arch Gynecol Obstet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.path.2010.12.007","article-title":"Atypical endometrial hyperplasia and well differentiated endometrioid adenocarcinoma of the uterine corpus","volume":"4","author":"Mills AM","year":"2011","unstructured":"Mills AM, Longacre TA. Atypical endometrial hyperplasia and well differentiated endometrioid adenocarcinoma of the uterine corpus. Surg Pathol Clin. 2011, 4:149-98. 10.1016\/j.path.2010.12.007","journal-title":"Surg Pathol Clin"},{"key":"ref4","article-title":"E-cadherin and alpha-catenin expression in normal, hyperplastic and neoplastic endometrium","volume":"30","author":"Carico E","year":"2010","unstructured":"Carico E, Atlante M, Giarnieri E, Raffa S, Bucci B, Giovagnoli MR, Vecchione A. E-cadherin and alpha-catenin expression in normal, hyperplastic and neoplastic endometrium. Anticancer Res. 2010, 30:4993-7.","journal-title":"Anticancer Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1177\/147323000903700119","article-title":"E-cadherin expression in endometrial malignancies: comparison between endometrioid and non-endometrioid carcinomas","volume":"37","author":"Yalta T","year":"2009","unstructured":"Yalta T, Atay L, Atalay F, Caydere M, Gonultas M, Ustun H. E-cadherin expression in endometrial malignancies: comparison between endometrioid and non-endometrioid carcinomas. J Int Med Res. 2009, 37:163-8. 10.1177\/147323000903700119","journal-title":"J Int Med Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-008-8281-1","article-title":"The cell-cell adhesion molecule E-cadherin","volume":"65","author":"van Roy F","year":"2008","unstructured":"van Roy F, Berx G. The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci. 2008, 65:3756-88. 10.1007\/s00018-008-8281-1","journal-title":"Cell Mol Life Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2021.12522","article-title":"Expression level of E-, N- and P-cadherin proteins in endometrial cancer","volume":"21","author":"Lewczuk \u0141","year":"2021","unstructured":"Lewczuk \u0141, Pryczynicz A, Guzi\u0144ska-Ustymowicz K. Expression level of E-, N- and P-cadherin proteins in endometrial cancer. Oncol Lett. 2021, 21:261. 10.3892\/ol.2021.12522","journal-title":"Oncol Lett"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnci.2014.08.002","article-title":"E-cadherin and CD10 expression in atypical hyperplastic and malignant endometrial lesions","volume":"26","author":"Ahmed AR","year":"2014","unstructured":"Ahmed AR, Muhammad EM. E-cadherin and CD10 expression in atypical hyperplastic and malignant endometrial lesions. J Egypt Natl Canc Inst. 2014, 26:211-7. 10.1016\/j.jnci.2014.08.002","journal-title":"J Egypt Natl Canc Inst"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/PGP.0000000000000492","article-title":"Could E-cadherin and CD10 expression be used to differentiate between atypical endometrial hyperplasia and endometrial carcinoma?","volume":"38","author":"Youssef MY","year":"2019","unstructured":"Youssef MY, Mohamed MA. Could E-cadherin and CD10 expression be used to differentiate between atypical endometrial hyperplasia and endometrial carcinoma?. Int J Gynecol Pathol. 2019, 38:128-37. 10.1097\/PGP.0000000000000492","journal-title":"Int J Gynecol Pathol"},{"key":"ref10","article-title":"Expression of E-cadherin and catenin (alpha-, beta-catenin) in endometrial cancer and atypical complex endometrial hyperplasia","volume":"48","author":"Yang YJ","year":"2005","unstructured":"Yang YJ, Lee HJ, Lee KH, et al.. Expression of E-cadherin and catenin (alpha-, beta-catenin) in endometrial cancer and atypical complex endometrial hyperplasia. Korean J Obstet Gynecol. 2005, 48:1456-65.","journal-title":"Korean J Obstet Gynecol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0b013e31826302a3","article-title":"Predicting the coexistence of an endometrial adenocarcinoma in the presence of atypical complex hyperplasia: immunohistochemical analysis of endometrial samples","volume":"22","author":"Robbe EJ","year":"2012","unstructured":"Robbe EJ, van Kuijk SM, de Boed EM, Smits LJ, van der Wurff AA, Kruitwagen RF, Pijnenborg JM. Predicting the coexistence of an endometrial adenocarcinoma in the presence of atypical complex hyperplasia: immunohistochemical analysis of endometrial samples. Int J Gynecol Cancer. 2012, 22:1264-72. 10.1097\/IGC.0b013e31826302a3","journal-title":"Int J Gynecol Cancer"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1080\/00016340802253775","article-title":"MMP-2, TIMP-1, E-cadherin, and beta-catenin expression in endometrial serous carcinoma compared with low-grade endometrial endometrioid carcinoma and proliferative endometrium","volume":"87","author":"Shaco-Levy R","year":"2008","unstructured":"Shaco-Levy R, Sharabi S, Piura B, Sion-Vardy N. MMP-2, TIMP-1, E-cadherin, and beta-catenin expression in endometrial serous carcinoma compared with low-grade endometrial endometrioid carcinoma and proliferative endometrium. Acta Obstet Gynecol Scand. 2008, 87:868-74. 10.1080\/00016340802253775","journal-title":"Acta Obstet Gynecol Scand"},{"key":"ref13","article-title":"Combined E-cadherin, alpha-catenin, and beta-catenin expression is a favorable prognostic factor in endometrial carcinoma","volume":"16","author":"Scholten AN","year":"2006","unstructured":"Scholten AN, Aliredjo R, Creutzberg CL, Smit VT. Combined E-cadherin, alpha-catenin, and beta-catenin expression is a favorable prognostic factor in endometrial carcinoma. Int J Gynecol Cancer. 2006, 16:1379-85.","journal-title":"Int J Gynecol Cancer"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1994.1113","article-title":"Decreased E-cadherin expression in endometrial carcinoma is associated with tumor dedifferentiation and deep myometrial invasion","volume":"53","author":"Sakuragi N","year":"1994","unstructured":"Sakuragi N, Nishiya M, Ikeda K, et al.. Decreased E-cadherin expression in endometrial carcinoma is associated with tumor dedifferentiation and deep myometrial invasion. Gynecol Oncol. 1994, 53:183-9. 10.1006\/gyno.1994.1113","journal-title":"Gynecol Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/path.1310","article-title":"Abnormalities of E- and P-cadherin and catenin (beta-, gamma-catenin, and p120ctn) expression in endometrial cancer and endometrial atypical hyperplasia","volume":"199","author":"Moreno-Bueno G","year":"2003","unstructured":"Moreno-Bueno G, Hardisson D, Sarri\u00f3 D, et al.. Abnormalities of E- and P-cadherin and catenin (beta-, gamma-catenin, and p120ctn) expression in endometrial cancer and endometrial atypical hyperplasia. J Pathol. 2003, 199:471-8. 10.1002\/path.1310","journal-title":"J Pathol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/263680-expression-of-e-cadherin-in-hyperplastic-endometrium-a-retrospective-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T03:51:21Z","timestamp":1721793081000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/263680-expression-of-e-cadherin-in-hyperplastic-endometrium-a-retrospective-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,23]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.65225","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,23]]}}}